North Chicago Business
-
Abbott abandons plans to sell vaccines businessSep 02, 2010 11:00 pm - WASHINGTON -- Drug and medical device firm Abbott Laboratories said Friday it has abandoned plans to sell its vaccines unit, less than three months after exploring sales...
-
Abbott's Meridia raises heart attack, stroke risk in studySep 01, 2010 11:00 pm - Abbott Laboratories' weight-loss pill Meridia increases the risk of heart attacks and strokes in people with heart disease, according to a study published in the New Eng...
-
Eisai, Abbott seek wider use of Humira in JapanAug 29, 2010 11:00 pm - Eisai Co. and Abbott Laboratories are seeking Japanese approval for wider use of the arthritis medicine Humira. The companies sought approval to use the monoclonal antib...
-
Abbott Labs' Humira honoredAug 24, 2010 11:00 pm - Merck & Co.'s Remicade, Pfizer Inc.'s Enbrel and Libertyville Township-based Abbott Laboratories' Humira won the backing of the U.K. National Institute for Health and Cl...
-
Abbott's Simcor gains approvalJul 28, 2010 11:00 pm - Libertyville Township-based Abbott received U.S. Food and Drug Administration approval for two new dosage strengths of Simcor, a cholesterol medication. The new dosage s...
-
Abbott settles patent suit with Teva over antibiotic OmnicefJul 18, 2010 11:00 pm - Abbott Laboratories said it settled a patent-infringement lawsuit filed against Teva Pharmaceutical Industries Ltd. over generic versions of the antibiotic Omnicef. Term...
-
Research: Merck AIDS drug as effective as Abbott pillsJul 18, 2010 11:00 pm - Merck & Co.'s Isentress tablets suppressed HIV as successfully as older drugs by Abbott Laboratories and Gilead Sciences Inc., according to research that may spur sales....
-
Abbott Labs plans $3 billion debt offeringMay 23, 2010 11:00 pm - Abbott Laboratories, maker of the arthritis drug Humira, may issue $3 billion of notes in the biggest U.S. corporate bond sale in a month. The offering comprises $750 mi...
-
Abbott buys unit of Piramal Healthcare for $3.7 bilMay 20, 2010 11:00 pm - MUMBAI, India -- Abbott Laboratories has agreed to buy the domestic healthcare business of India's Piramal Healthcare Ltd., a leading branded generics company, for $3.72...
-
Abbott's Humira to be covered by U.K. national health plansMay 18, 2010 11:00 pm - Abbott Laboratories' Humira and Merck & Co.'s Remicade should be covered by the U.K.'s National Health Service for adults with severe Crohn's disease that doesn't respon...